Sun Can't Sell Generic Eloxatin Until 2012: Judge
Sun Pharmaceutical Industries Ltd. can't market its generic version of Sanofi-Aventis SA's colorectal cancer treatment Eloxatin until August 2012, based on the terms of a licensing agreement between the companies, a...To view the full article, register now.
Already a subscriber? Click here to view full article